Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users

Objectives: As the legal and cultural landscape surrounding cannabis use in the United States continues to evolve, more Americans are turning to cannabis to self-medicate a number of ailments, including migraines. The purpose of the present study was to examine patterns of cannabis use and its assoc...

Full description

Bibliographic Details
Main Authors: Laurel P. Gibson, Leah N. Hitchcock, Angela D. Bryan, L. Cinnamon Bidwell
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Complementary Therapies in Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0965229920318860
id doaj-b274465cd5a946d78013b1495a46cf35
record_format Article
spelling doaj-b274465cd5a946d78013b1495a46cf352021-06-05T06:03:17ZengElsevierComplementary Therapies in Medicine0965-22992021-01-0156102619Experience of migraine, its severity, and perceived efficacy of treatments among cannabis usersLaurel P. Gibson0Leah N. Hitchcock1Angela D. Bryan2L. Cinnamon Bidwell3Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA; Corresponding author at: Department of Psychology and Neuroscience, Muenzinger Building, Boulder, CO 80309, USA.Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA; Institute of Cognitive Science, University of Colorado, Boulder, CO, USADepartment of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA; Institute of Cognitive Science, University of Colorado, Boulder, CO, USADepartment of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA; Institute of Cognitive Science, University of Colorado, Boulder, CO, USAObjectives: As the legal and cultural landscape surrounding cannabis use in the United States continues to evolve, more Americans are turning to cannabis to self-medicate a number of ailments, including migraines. The purpose of the present study was to examine patterns of cannabis use and its associated relief among migraineurs. Design: Participants were N = 589 adult cannabis users living in states with full legal access. Using a cross-sectional design, participants completed an online survey assessing their cannabis use profiles, migraine experience, and self-reported relief from cannabis and non-cannabis treatments. Results: 161 participants (27.3 %) reported experiencing migraines. 76.4 % of migraineurs (N = 123) endorsed using cannabis to treat their migraines. 69.9 % (N = 86) of migraineurs using cannabis for migraine relief also endorsed using non-cannabis products (e.g., over-the-counter pain medication, triptans) to treat their migraines. Although their subjective health was similar (p = .17), migraineurs who endorsed using cannabis to treat their migraines reported more severe migraines compared to those who did not (p = .02). Migraineurs reported significantly more migraine relief from cannabis compared to non-cannabis products, even after controlling for migraine severity (p = .03). The majority of migraineurs using cannabis to treat their migraines were not medical cardholders (65.0 %), suggesting that these individuals were self-medicating in lieu of physician guidance. Conclusions: The present study provides insight into the prevalence of cannabis use for migraine relief in a sample of cannabis users, and suggests that these migraineurs experience a high level of migraine relief from cannabis. Future studies are needed to determine the cannabis forms, potencies, and dosages that are most effective at treating migraine pain.http://www.sciencedirect.com/science/article/pii/S0965229920318860MigraineHeadacheCannabisMarijuanaPain
collection DOAJ
language English
format Article
sources DOAJ
author Laurel P. Gibson
Leah N. Hitchcock
Angela D. Bryan
L. Cinnamon Bidwell
spellingShingle Laurel P. Gibson
Leah N. Hitchcock
Angela D. Bryan
L. Cinnamon Bidwell
Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
Complementary Therapies in Medicine
Migraine
Headache
Cannabis
Marijuana
Pain
author_facet Laurel P. Gibson
Leah N. Hitchcock
Angela D. Bryan
L. Cinnamon Bidwell
author_sort Laurel P. Gibson
title Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
title_short Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
title_full Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
title_fullStr Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
title_full_unstemmed Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
title_sort experience of migraine, its severity, and perceived efficacy of treatments among cannabis users
publisher Elsevier
series Complementary Therapies in Medicine
issn 0965-2299
publishDate 2021-01-01
description Objectives: As the legal and cultural landscape surrounding cannabis use in the United States continues to evolve, more Americans are turning to cannabis to self-medicate a number of ailments, including migraines. The purpose of the present study was to examine patterns of cannabis use and its associated relief among migraineurs. Design: Participants were N = 589 adult cannabis users living in states with full legal access. Using a cross-sectional design, participants completed an online survey assessing their cannabis use profiles, migraine experience, and self-reported relief from cannabis and non-cannabis treatments. Results: 161 participants (27.3 %) reported experiencing migraines. 76.4 % of migraineurs (N = 123) endorsed using cannabis to treat their migraines. 69.9 % (N = 86) of migraineurs using cannabis for migraine relief also endorsed using non-cannabis products (e.g., over-the-counter pain medication, triptans) to treat their migraines. Although their subjective health was similar (p = .17), migraineurs who endorsed using cannabis to treat their migraines reported more severe migraines compared to those who did not (p = .02). Migraineurs reported significantly more migraine relief from cannabis compared to non-cannabis products, even after controlling for migraine severity (p = .03). The majority of migraineurs using cannabis to treat their migraines were not medical cardholders (65.0 %), suggesting that these individuals were self-medicating in lieu of physician guidance. Conclusions: The present study provides insight into the prevalence of cannabis use for migraine relief in a sample of cannabis users, and suggests that these migraineurs experience a high level of migraine relief from cannabis. Future studies are needed to determine the cannabis forms, potencies, and dosages that are most effective at treating migraine pain.
topic Migraine
Headache
Cannabis
Marijuana
Pain
url http://www.sciencedirect.com/science/article/pii/S0965229920318860
work_keys_str_mv AT laurelpgibson experienceofmigraineitsseverityandperceivedefficacyoftreatmentsamongcannabisusers
AT leahnhitchcock experienceofmigraineitsseverityandperceivedefficacyoftreatmentsamongcannabisusers
AT angeladbryan experienceofmigraineitsseverityandperceivedefficacyoftreatmentsamongcannabisusers
AT lcinnamonbidwell experienceofmigraineitsseverityandperceivedefficacyoftreatmentsamongcannabisusers
_version_ 1721397193508651008